Acute Myelogenous Leukemia
Springer-Verlag New York Inc.
978-1-4419-1299-2 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Lalitha Nagarajan is an Associate Professor, Department of Molecular Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
The Leukemia Stem Cell.- Epigenetic Mechanisms in AML - a Target for Therapy.- Chromosomal Translocations in AML: Detection and Prognostic Significance.- Chromosomal Deletions in AML.- Genes Predictive of Outcome and Novel Molecular Classification Schemes in Adult Acute Myeloid Leukemia.- Receptor Tyrosine Kinase Alterations in AML -- Biology and Therapy.- Lineage Specific Transcription Factor Aberrations in AML.- Pro-leukemic RUNX1 and CBFss Mutations in the Pathogenesis of Acute Leukemia.- Acute Myeloid Leukemia with Mutated Nucleophosmin (NPM1): Molecular, Pathological and Clinical Features.- MicroRNAs: New Players in AML Pathogenesis.- Murine Models of Human Acute Myeloid Leukemia.- AML and Apoptosis.- Acute Promyelocytic Leukemia, a Paradigm for Differentitation Therapy.- Immunotherapy of AML.- Therapy of Acute Myelogenous Leukemia in Adults.
Erscheint lt. Verlag | 1.10.2009 |
---|---|
Reihe/Serie | Cancer Treatment and Research ; v. 145 |
Zusatzinfo | 5 black & white illustrations, 20 colour illustrations |
Verlagsort | New York, NY |
Sprache | englisch; Multiple languages |
Maße | 155 x 235 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
ISBN-10 | 1-4419-1299-1 / 1441912991 |
ISBN-13 | 978-1-4419-1299-2 / 9781441912992 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich